US Broker Ratings

Schrodinger, Inc. (SDGR) Stock Analysis: Navigating Highs with a 52-Week Peak Amidst Analyst Skepticism

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the health information services sector, is making waves in the market with its recent price performance, hitting the upper echelon of its..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Unpacking a 59.91% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a compelling prospect in the biotechnology sector, boasting a market capitalization of $9.69 billion. As a key player in the healthcare sector, Arrowhead is..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 106% Upside in the Biotechnology Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) has captured investor attention with a potential upside of 106.47%, according to recent analyst ratings. As a player in the biotechnology industry, Beam Therapeutics is..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Unlocking a 25% Upside Potential with Strong Buy Ratings

Kiniksa Pharmaceuticals Interna (NASDAQ: KNSA) is catching the eye of investors with its robust growth trajectory and promising market position in the healthcare sector. This UK-based biopharmaceutical company, with a..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Powerhouse with a 26% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is making waves in the biotechnology sector, particularly in the field of eye care therapeutics. With a market capitalization of $3.62 billion, this Irvine, California-based..

Immunovant, Inc. (IMVT) Stock Analysis: Potential Upside and Strong Buy Ratings Make This Biotech a Compelling Investment

Investors looking to capitalize on the potential within the biotech sector might find Immunovant, Inc. (NASDAQ: IMVT) a particularly intriguing opportunity. With a market capitalization of $7.68 billion, this Durham,..

Travere Therapeutics, Inc. (TVTX): Investor Outlook and 18% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with a focus on developing therapies for rare kidney and metabolic diseases. The San Diego-based company, with a market..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 49.55% Potential Upside in the Biotech Sector

As individual investors eye opportunities in the biotechnology sector, Biohaven Ltd. (NASDAQ: BHVN) presents a compelling case with a notable potential upside of 49.55%. Based in New Haven, Connecticut, Biohaven..

AtriCure, Inc. (ATRC) Stock Analysis: Insights into a Healthcare Growth Story with a 12.8% Revenue Boost

For investors eyeing the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents a compelling narrative of innovation and growth. Specializing in medical instruments and supplies, AtriCure has carved out a niche..

Brookdale Senior Living Inc. (BKD)

⚠️ No article content returned.

..

Addus HomeCare Corporation (ADUS): Investor Outlook on the Healthcare Leader with 15.76% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, has been steadily garnering investor attention. With a market capitalization of $2.15 billion, Addus operates within the medical..

Haemonetics Corporation (HAE) Stock Analysis: A Medical Device Leader with a Solid Growth Trajectory

Haemonetics Corporation (NYSE: HAE) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of approximately $4.95 billion, Haemonetics has established..

Viking Therapeutics (VKTX) Stock Analysis: Is a 206% Upside Within Reach for This Biotech Innovator?

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing the attention of investors with its substantial potential upside and a promising pipeline of novel therapies targeting metabolic and endocrine disorders. As..

BGM Group Ltd. (BGM) Stock Analysis: Unpacking Growth Potential Amidst Recent Turbulence

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, is currently navigating a complex landscape marked by significant volatility. With a market capitalization of $102.56 million, BGM operates..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 26% Potential Upside

For investors with an eye on the healthcare sector, UFP Technologies, Inc. (UFPT) presents an intriguing opportunity. This US-based medical device company, with a market cap of $2.18 billion, has..

Ardent Health, Inc. (ARDT) Stock Analysis: Healthcare Giant with a 20% Upside Potential

Ardent Health, Inc. (ARDT), a prominent player in the Medical Care Facilities industry, is making waves in the healthcare sector with its expansive network of hospitals and clinics across the..

CG Oncology (CGON) Stock Analysis: Exploring the 16.39% Potential Upside in Biotech Innovation

In the ever-evolving landscape of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) stands out as a company with promising potential. With a market capitalization of $6.94 billion, CG Oncology is making..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 97.83 USD Current Price Amidst a 52-Week High of 167.51 USD

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is creating ripples among investors with its focus on genomics and..

Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside in the Biotech Arena

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its promising position in the biotechnology sector, particularly in the niche of hematologic diseases. Despite the inherent volatility..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds